Sweden-based Alligator Bioscience AB has appointed Christina Reimer as chief medical officer, effective 1 February 2021, as it progresses three new cancer therapies in the clinic. She joins from Ferring Pharmaceuticals in Copenhagen where she was senior medical director. Dr Reimer will report to Malin Carlsson, the head of R&D, and be part of Alligator’s management team.
Dr Reimer is a medical doctor and holds a PhD in gastroenterology.
Alligator Bioscience announced the appointment on 29 December 2020.
Copyright 2020 Evernow Publishing Ltd